[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345823-105":59,"doc-detail-345823-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","emerging-new-pathways-in-malignant-neoplasms-and-neurodegenerative-disorders-perspectives-for-therapeutics","Emerging New Pathways in Malignant Neoplasms and Neurodegenerative Disorders - Perspectives for Therapeutics","","Neurodegenerative disorders such as Alzheimer’s disease and malignant neoplasms are among the most common age-associated conditions. Despite opposing clinical phenotypes—uncontrolled proliferation and metabolic reprogramming in cancer versus synaptic dysfunction, neuronal loss, neuroinflammation, and impaired proteostasis in neurodegeneration—epidemiological and molecular evidence indicates an inverse cancer–neurodegeneration relationship. The review clarifies how aging-related pathway dysregulation may drive divergent outcomes, links specific cancers to neurodegenerative diagnoses, contrasts shared and opposing mechanisms, and outlines therapeutic opportunities while addressing risks.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/emerging-new-pathways-in-malignant-neoplasms-and-neurodegenerative-disorders-perspectives-for-therapeutics/345823/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/emerging-new-pathways-in-malignant-neoplasms-and-neurodegenerative-disorders-perspectives-for-therapeutics/345823.png","ImageObject",300,407,{"name":92,"@type":93},"Eden","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does the review report about the inverse relationship between cancer and neurodegeneration?","Question",{"text":112,"@type":113},"The inverse cancer–neurodegeneration relationship is not uniform. It varies by cancer type and neurodegenerative diagnosis, with stronger inverse patterns reported for AD and PD/Lewy body spectrum disorders, reduced cancer prevalence in FTLD, and melanoma noted as an important exception in PD.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which shared biological pathways are discussed as potentially linking cancer and neurodegeneration?",{"text":117,"@type":113},"The review highlights aging-related pathway trajectories involving PI3K–AKT–mTOR, p53/DNA damage responses, IGF/MAPK, BCL-2, proteostasis/autophagy, senescence/SASP signaling, and transcriptomic/genetic programs that may shift toward either malignant proliferation or neurodegenerative vulnerability.",{"name":119,"@type":110,"acceptedAnswer":120},"Why does the review emphasize careful interpretation of observed associations?",{"text":121,"@type":113},"It calls for pathology-resolved and cancer subtype-specific analyses to distinguish true biological inverse relationships from survival bias, diagnostic ascertainment, treatment effects, and mixed dementia pathology.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345823,1790455897,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Review  \nEmerging New Pathways in Malignant Neoplasms and Neurodegenerative Disorders: Perspectives for Therapeutics  \nWolf Wrasidlo 1 and Eliezer Masliah 2, *,†  \nAcademic Editor: Katsuhiko Tabuchi  \nReceived: 25 May 2026  \nRevised: 23 June 2026  \nAccepted: 26 June 2026  \nPublished: 29 June 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Radiation Medicine and Applied Sciences Department, University of California, San Diego, CA 92093, USA  \n2 Department of Neurosciences, University of California, San Diego, CA 92093, USA  \n* Correspondence: [emasliah@ucsd.edu](emasliah@ucsd.edu)[ ](emasliah@ucsd.edu)† Retired.  \nHighlights  \nWhat are the main findings?  \n• The inverse cancer–neurodegeneration relationship is not uniform; it varies by cancer type and neurodegenerative diagnosis, with stronger inverse patterns for AD and PD/Lewy body spectrum disorders, reduced overall cancer prevalence reported in FTLD, and melanoma representing an important exception in PD.  \n• Cancer and neurodegeneration may reflect divergent aging-related pathway trajectories, involving PI3K–AKT–mTOR, p53/DNA damage responses, IGF/MAPK, BCL-2, proteostasis/autophagy, senescence/SASP signaling, and transcriptomic/genetic programs that can shift toward malignant proliferation or neurodegenerative vulnerability.  \nWhat are the implications of the main findings?  \n• Pathology-resolved and cancer subtype-specific analyses are needed to distinguish true biological inverse relationships from survival bias, diagnostic ascertainment, treatment effects, and mixed dementia pathology.  \n• The cancer–neurodegeneration interface may reveal therapeutic opportunities, including oncology-derived kinase inhibitors, lysosomal modulators, epigenetic modulators, senolytics, and transcriptomic drug-repurposing strategies, but interventions must account for the trade-off between enhancing neuronal survival and increasing oncogenic risk.  \nAbstract  \nNeurodegenerative disorders such as Alzheimer’s disease (AD) and malignant neoplasms are among the most prevalent age-associated diseases worldwide. Although cancer is characterized by uncontrolled proliferation, resistance to apoptosis, and metabolic reprogramming, AD and other neurodegenerative disorders such as Lewy body disease (LBD) including Parkinson’s Disease (PD) and fronto-temporal lobar degeneration (FTLD) are defined by synaptic dysfunction, neuronal loss, neuroinflammation, and impaired proteostasis with misfolded protein aggregates. Despite these contrasting phenotypes, converging epidemiological and molecular data support an inverse relationship between cancer and neurodegenerative disorders, whereby a history of cancer is associated with reduced AD risk, whereas AD is linked to a lower incidence of multiple malignancies. These observations suggest that oncogenesis and neurodegeneration may represent divergent outcomes of shared biological processes dysregulated during aging. This conundrum likely reflects differential regulation of core cellular pathways governing cell survival, stress responses, metabolism, and genomic integrity but could also reflect the differential influence of aging pathways and secreted growth factors. Pro-survival and proliferative  \nsignaling pathways commonly activated in cancer, including PI3K–AKT–mTOR signaling, altered p53 function, enhanced DNA damage tolerance, and anabolic metabolism, are often impaired in AD, LBD and FTLD, where neurons exhibit heightened vulnerability to stress, mitochondrial dysfunction, defective autophagy, and activation of pro-apoptotic cascades. Conversely, tumor-suppressive mechanisms that restrain proliferation may protect against malignancy but increase susceptibility to degeneration in post-mitotic neurons. Aging-related processes such as cellular senescence, immune dysregulation, and loss of pr","cbCaimTISEkE3DtV","https://ap.wps.com/l/cbCaimTISEkE3DtV","pdf",7251093,29,"English","# Highlights\n## Main findings\n## Implications of the main findings\n# Abstract\n# Keywords\n# Introduction","[{\"question\":\"What does the review report about the inverse relationship between cancer and neurodegeneration?\",\"answer\":\"The inverse cancer–neurodegeneration relationship is not uniform. It varies by cancer type and neurodegenerative diagnosis, with stronger inverse patterns reported for AD and PD/Lewy body spectrum disorders, reduced cancer prevalence in FTLD, and melanoma noted as an important exception in PD.\"},{\"question\":\"Which shared biological pathways are discussed as potentially linking cancer and neurodegeneration?\",\"answer\":\"The review highlights aging-related pathway trajectories involving PI3K–AKT–mTOR, p53/DNA damage responses, IGF/MAPK, BCL-2, proteostasis/autophagy, senescence/SASP signaling, and transcriptomic/genetic programs that may shift toward either malignant proliferation or neurodegenerative vulnerability.\"},{\"question\":\"Why does the review emphasize careful interpretation of observed associations?\",\"answer\":\"It calls for pathology-resolved and cancer subtype-specific analyses to distinguish true biological inverse relationships from survival bias, diagnostic ascertainment, treatment effects, and mixed dementia pathology.\"}]","Emerging New Pathways in Malignant Neoplasms and Neurodegenerative Disorders - Perspectives for Therapeutics | PDF",1790058993,73,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/065bc674819d4911a0b877b9f4ba07b6.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a4252d0ec196f218e2999d4ce8fa78a3.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/776e400136317d49926a494b67b9a321.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e8ccfaabcbebd8e7686ace61bf9e1695.webp",980,1385]